Lilly to Invest $5.3 Billion for Weight-Loss Drug Supply
Eli Lilly & Co. will spend $5.3 billion to boost production of a key ingredient in its weight-loss and diabetes shots after the treatments’ explosive popularity led to shortages. Simone Foxman reports. #press
